{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:48:38Z","timestamp":1791924518336,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFF0720300"],"award-info":[{"award-number":["2023YFF0720300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005891","name":"State Administration of Traditional Chinese Medicine of the People's Republic of China","doi-asserted-by":"publisher","award":["ZYYCXTD-D-202209"],"award-info":[{"award-number":["ZYYCXTD-D-202209"]}],"id":[{"id":"10.13039\/501100005891","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.tice.2026.104031","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:44:01Z","timestamp":1791416641000},"page":"104031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P3","title":["Natural product cephalomannine suppresses triple-negative breast cancer progression by targeting VEGFR1 signaling"],"prefix":"10.1016","volume":"104","author":[{"given":"Qingqing","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingzhou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congcong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianya","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinran","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tice.2026.104031_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2024.102577","article-title":"Cephalomannine reduces radiotherapy resistance in non-small cell lung cancer cells by blocking the \u03b2-catenin-BMP2 signaling pathway","volume":"91","author":"An","year":"2024","journal-title":"Tissue Cell."},{"key":"10.1016\/j.tice.2026.104031_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1676768","article-title":"A tumor immune microenvironment gene expression signature for predicting prognosis, immunotherapy efficacy, and drug candidates in triple-negative breast cancer","volume":"16","author":"Bai","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tice.2026.104031_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084408","article-title":"Synergistic anti-angiogenic effect of combined VEGFR kinase inhibitors, lenvatinib, and regorafenib: a therapeutic potential for breast cancer","volume":"23","author":"Bajbouj","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tice.2026.104031_bib4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tice.2026.104031_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.reth.2023.06.014","article-title":"Investigation of L-carnitine effects on CD44+ cancer stem cells from MDA-MB-231 breast cancer cell line as anti-cancer therapy","volume":"24","author":"Farahzadi","year":"2023","journal-title":"Regen. Ther."},{"key":"10.1016\/j.tice.2026.104031_bib6","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1158\/1078-0432.CCR-18-2123","article-title":"VEGFR1(+) metastasis-associated macrophages contribute to metastatic angiogenesis and influence colorectal cancer patient outcome","volume":"25","author":"Freire Valls","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tice.2026.104031_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.fitote.2013.07.011","article-title":"Synthesis, isolation, stereostructure and cytotoxicity of paclitaxel analogs from cephalomannine","volume":"90","author":"Gao","year":"2013","journal-title":"Fitoterapia"},{"key":"10.1016\/j.tice.2026.104031_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/antiox14091037","article-title":"Paclitaxel and cephalomannine synergistically induce panoptosis in triple-negative breast cancer through oxygen-regulated cell death pathways","volume":"14","author":"Gao","year":"2025","journal-title":"Antioxidants"},{"key":"10.1016\/j.tice.2026.104031_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/biom12101359","article-title":"Identification of the thyrotropin-releasing hormone (TRH) as a novel biomarker in the prognosis for acute myeloid leukemia","volume":"12","author":"Gao","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.tice.2026.104031_bib10","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1093\/annonc\/mdu124","article-title":"Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer","volume":"25","author":"Gonzalez-Angulo","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.tice.2026.104031_bib11","article-title":"C\/EBP\u03b2 stabilizes oxidative stress in triple-negative breast cancer cells, driving taxane resistance and immune evasion","author":"Holm","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tice.2026.104031_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2016.11.024","article-title":"Triple-amiRNA VEGFRs inhibition in pancreatic cancer improves the efficacy of chemotherapy through EMT regulation","volume":"245","author":"Huang","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.tice.2026.104031_bib13","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/nprot.2014.138","article-title":"The cellular thermal shift assay for evaluating drug target interactions in cells","volume":"9","author":"Jafari","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.tice.2026.104031_bib14","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1073\/pnas.1200305109","article-title":"Versatile pathway-centric approach based on high-throughput sequencing to anticancer drug discovery","volume":"109","author":"Li","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"50","key":"10.1016\/j.tice.2026.104031_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.75937","article-title":"Multifunctional responsive nanoplatform as immunotherapeutic regulator to target triple-negative breast cancers via mechanotransduction","volume":"36","author":"Li","year":"2026","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.tice.2026.104031_bib16","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1093\/bib\/bbz129","article-title":"A comprehensive evaluation of connectivity methods for L1000 data","volume":"21","author":"Lin","year":"2020","journal-title":"Brief. Bioinform"},{"key":"10.1016\/j.tice.2026.104031_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118273","article-title":"Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF\/VEGFR2\/Src signaling pathway","volume":"259","author":"Liu","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.tice.2026.104031_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1381251","article-title":"Potential therapeutic targets of the JAK2\/STAT3 signaling pathway in triple-negative breast cancer","volume":"14","author":"Long","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tice.2026.104031_bib19","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(20)31953-X","article-title":"Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial","volume":"396","author":"Mittendorf","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.tice.2026.104031_bib20","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1186\/s12885-025-14902-6","article-title":"Cephalomannine as in vitro and in vivo anticancer agent in mesothelioma cells: mechanisms of action","volume":"25","author":"Morani","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tice.2026.104031_bib21","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.7150\/ijbs.72629","article-title":"UBE2S as a novel ubiquitinated regulator of p16 and \u03b2-catenin to promote bone metastasis of prostate cancer","volume":"18","author":"Peng","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.tice.2026.104031_bib22","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1084\/jem.20141555","article-title":"FLT1 signaling in metastasis-associated macrophages activates an inflammatory signature that promotes breast cancer metastasis","volume":"212","author":"Qian","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tice.2026.104031_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11082311","article-title":"Renal disorders with oral tyrosine kinase inhibitors in metastatic colorectal cancer: an analysis from the FDA adverse event reporting system database","volume":"11","author":"Russo","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.tice.2026.104031_bib24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s13238-018-0533-8","article-title":"Chemical genomics reveals inhibition of breast cancer lung metastasis by Ponatinib via c-Jun","volume":"10","author":"Shao","year":"2019","journal-title":"Protein Cell."},{"key":"10.1016\/j.tice.2026.104031_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9080876","article-title":"TNBC: potential targeting of multiple receptors for a therapeutic breakthrough, nanomedicine, and immunotherapy","volume":"9","author":"Singh","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.tice.2026.104031_bib26","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A next generation connectivity Map: L1000 platform and the first 1,000,000 profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.tice.2026.104031_bib27","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41419-021-03771-z","article-title":"Cephalomannine inhibits hypoxia-induced cellular function via the suppression of APEX1\/HIF-1\u03b1 interaction in lung cancer","volume":"12","author":"Ullah","year":"2021","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.tice.2026.104031_bib28","article-title":"Oxyresveratrol as a novel ferroptosis inducer exhibits anticancer activity against breast cancer via the EGFR\/PI3K\/AKT\/GPX4 signalling axis","volume":"15","author":"Xiang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tice.2026.104031_bib29","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/s41592-025-02781-5","article-title":"High-throughput profiling of chemical-induced gene expression across 93,644 perturbations","volume":"22","author":"Xiang","year":"2025","journal-title":"Nat. Methods"},{"key":"10.1016\/j.tice.2026.104031_bib30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.kint.2025.03.021","article-title":"Gene signature-guided drug screening identified narciclasine as a potential therapeutic for interstitial fibrosis of the kidney","volume":"108","author":"Xiao","year":"2025","journal-title":"Kidney Int."},{"key":"10.1016\/j.tice.2026.104031_bib31","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/s41419-023-05938-2","article-title":"UBE2S interacting with TRIM21 mediates the K11-linked ubiquitination of LPP to promote the lymphatic metastasis of bladder cancer","volume":"14","author":"Xiao","year":"2023","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.tice.2026.104031_bib32","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/toxsci\/kfae127","article-title":"Schisandrin C prevents regorafenib-induced cardiotoxicity by recovering EPHA2 expression in cardiomyocytes","volume":"202","author":"Xu","year":"2024","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tice.2026.104031_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ph18091275","article-title":"Large-scale transcriptome profiling and network pharmacology analysis reveal the multi-target inhibitory mechanism of modified guizhi fuling decoction in prostate cancer cells","volume":"18","author":"Zhang","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.tice.2026.104031_bib34","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1124\/dmd.107.018242","article-title":"Taxane's substituents at C3' affect its regioselective metabolism: different in vitro metabolism of cephalomannine and paclitaxel","volume":"36","author":"Zhang","year":"2008","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.tice.2026.104031_bib35","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3350\/cmh.2024.0236","article-title":"UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL","volume":"30","author":"Zhang","year":"2024","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.tice.2026.104031_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105553","article-title":"Aurora kinase B inhibitor AZD1152: repurposing for treatment of lupus nephritis driven by the results of clinical trials","volume":"112","author":"Zhao","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.tice.2026.104031_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.113916","article-title":"EPYC promotes laryngeal cancer carcinogenesis and angiogenesis by docking to VEGFR1: A novel therapeutic target","volume":"28","author":"Zhou","year":"2025","journal-title":"iScience"},{"issue":"14","key":"10.1016\/j.tice.2026.104031_bib38","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1111\/febs.16768","article-title":"MAEL facilitates metabolic reprogramming and breast cancer progression by promoting the degradation of citrate synthase and fumarate hydratase via chaperone-mediated autophagy","volume":"290","author":"Zhou","year":"2023","journal-title":"FEBS J."}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816626007275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816626007275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:18:37Z","timestamp":1791922717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816626007275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":38,"alternative-id":["S0040816626007275"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2026.104031","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural product cephalomannine suppresses triple-negative breast cancer progression by targeting VEGFR1 signaling","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2026.104031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104031"}}